These data suggest that in immune competent murine models of B-ALL and lymphoma, IFNγ is important for tumor susceptibility to CAR-T cells in vivo and show that global blocking IFNγ did not enhance the in vivo efficacy of CAR-T cells. This evidence concerns the gene IFNG and precursor B-cell acute lymphoblastic leukemia.